Co-amplification of CCND1 and EMSY is associated with an adverse outcome in ER-positive tamoxifen-treated breast cancers. (Q45918155)
scientific article published on 28 July 2009
Language:
Current Data About Co-amplification of CCND1 and EMSY is associated with an adverse outcome in ER-positive tamoxifen-treated breast cancers.
(P31) (Q13442814)
(P248)
(P698) 19636701
(P813) Sunday, December 17, 2017
(P854) http://europepmc.org/abstract/MED/19636701

(P50) (Q37829195)
(P1545) 6
(P248)
(P698) 19636701
(P813) Sunday, December 17, 2017
(P854) http://europepmc.org/abstract/MED/19636701

(Q114166152)
(P1545) 7
(P1932) David G Huntsman
(P248)
(P698) 19636701
(P813) Sunday, December 17, 2017
(P854) http://europepmc.org/abstract/MED/19636701

(P304) 347-354
(P248)
(P698) 19636701
(P813) Sunday, December 17, 2017
(P854) http://europepmc.org/abstract/MED/19636701

(P407) (Q1860)

(P433) 2
(P248)
(P698) 19636701
(P813) Sunday, December 17, 2017
(P854) http://europepmc.org/abstract/MED/19636701

(P478) 121
(P248)
(P698) 19636701
(P813) Sunday, December 17, 2017
(P854) http://europepmc.org/abstract/MED/19636701

(P577) Tuesday, July 28, 2009
(P248)
(P698) 19636701
(P813) Sunday, December 17, 2017
(P854) http://europepmc.org/abstract/MED/19636701

(P921) (Q412178)
(P887)

(P1433) (Q326085)
(P248)
(P698) 19636701
(P813) Sunday, December 17, 2017
(P854) http://europepmc.org/abstract/MED/19636701

(P1476) "Co-amplification of CCND1 and EMSY is associated with an adverse outcome in ER-positive tamoxifen-treated breast cancers." (language: en)
(P248)
(P698) 19636701
(P813) Sunday, December 17, 2017
(P854) http://europepmc.org/abstract/MED/19636701

(P2093) Lindsay A Brown
(P1545) 1
(P248)
(P698) 19636701
(P813) Sunday, December 17, 2017
(P854) http://europepmc.org/abstract/MED/19636701

Karynn Johnson
(P1545) 2
(P248)
(P698) 19636701
(P813) Sunday, December 17, 2017
(P854) http://europepmc.org/abstract/MED/19636701

Samuel Leung
(P1545) 3
(P248)
(P698) 19636701
(P813) Sunday, December 17, 2017
(P854) http://europepmc.org/abstract/MED/19636701

Tarek A Bismar
(P1545) 4
(P248)
(P698) 19636701
(P813) Sunday, December 17, 2017
(P854) http://europepmc.org/abstract/MED/19636701

Javier Benítez
(P1545) 5
(P248)
(P698) 19636701
(P813) Sunday, December 17, 2017
(P854) http://europepmc.org/abstract/MED/19636701

(P2860) (Q36134760)
(P248)
(P854) https://api.crossref.org/works/10.1007%2FS10549-009-0479-X
(P813) Sunday, January 21, 2018

(Q35792001)
(P248)
(P854) https://api.crossref.org/works/10.1007%2FS10549-009-0479-X
(P813) Sunday, January 21, 2018

(Q36431320)
(P248)
(P854) https://api.crossref.org/works/10.1007%2FS10549-009-0479-X
(P813) Sunday, January 21, 2018

other details
description scientific article published on 28 July 2009

External Links
(P356) 10.1007/S10549-009-0479-X
(P698) 19636701
(P6179) 1009622563